Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

<p>All Supplementary Tables</p>

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awdur:	Evangeline R. Jackson (15558808) (author)
Awduron Eraill:	Ryan J. Duchatel (15558811) (author), Dilana E. Staudt (15558814) (author), Mika L. Persson (15558817) (author), Abdul Mannan (15558820) (author), Sridevi Yadavilli (15558823) (author), Sarah Parackal (15558826) (author), Shaye Game (15558829) (author), Wai Chin Chong (15558832) (author), W. Samantha N. Jayasekara (15558835) (author), Marion Le Grand (15558838) (author), Padraic S. Kearney (15558841) (author), Alicia M. Douglas (15558844) (author), Izac J. Findlay (15558847) (author), Zacary P. Germon (15558850) (author), Holly P. McEwen (15558853) (author), Tyrone S. Beitaki (15558856) (author), Adjanie Patabendige (15558859) (author), David A. Skerrett-Byrne (15558862) (author), Brett Nixon (9587818) (author), Nathan D. Smith (15558865) (author), Bryan Day (15558868) (author), Neevika Manoharan (15558871) (author), Sumanth Nagabushan (15558874) (author), Jordan R. Hansford (15022992) (author), Dinisha Govender (15558877) (author), Geoff B. McCowage (15558880) (author), Ron Firestein (15558883) (author), Meegan Howlett (15558886) (author), Raelene Endersby (15558889) (author), Nicholas G. Gottardo (15558892) (author), Frank Alvaro (15558895) (author), Sebastian M. Waszak (15042965) (author), Martin R. Larsen (15558898) (author), Yolanda Colino-Sanguino (15558901) (author), Fatima Valdes-Mora (15558904) (author), Andria Rakotomalala (15558907) (author), Samuel Meignan (15558910) (author), Eddy Pasquier (15558913) (author), Nicolas André (15119506) (author), Esther Hulleman (15558916) (author), David D. Eisenstat (15558919) (author), Nicholas A. Vitanza (15122158) (author), Javad Nazarian (15558922) (author), Carl Koschmann (15558925) (author), Sabine Mueller (15042968) (author), Jason E. Cain (15558928) (author), Matthew D. Dun (15122218) (author)
Cyhoeddwyd:	2025
Pynciau:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling CNS Cancers Drug Mechanisms Cellular responses to anticancer drugs Metabolism Mitochondrial function Pediatric Cancers Proteomics Rare Cancers Systems Biology
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
gan: Gwo Yaw Ho (14961416)
Cyhoeddwyd: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
gan: Alyssa C. Flint (16676029)
Cyhoeddwyd: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
gan: Alyssa C. Flint (16676029)
Cyhoeddwyd: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
gan: Nicole A. Traphagen (16677391)
Cyhoeddwyd: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
gan: Nicole A. Traphagen (16677391)
Cyhoeddwyd: (2025)

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
gan: Fang Wei (15057172)
Cyhoeddwyd: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
gan: Jesse C. Patterson (14962862)
Cyhoeddwyd: (2025)

Supplementary Table S1 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S2 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S3 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S4 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S5 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S6 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Table S7 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
gan: Amr El Zawily (14851115)
Cyhoeddwyd: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
gan: Lixuan Wei (14962431)
Cyhoeddwyd: (2025)

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
gan: Juliana Navarro-Yepes (17079059)
Cyhoeddwyd: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
gan: Michael D. Nyquist (16918265)
Cyhoeddwyd: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
gan: Michael D. Nyquist (16918265)
Cyhoeddwyd: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
gan: Jiwei Bai (15051797)
Cyhoeddwyd: (2025)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
gan: Zijing Wang (17141626)
Cyhoeddwyd: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ile7ioupu7cd54jfpbobnm9hcd